Vera Therapeutics
Gary Barrera serves as the Senior Vice President of Regulatory and Quality at Vera Therapeutics, Inc., a role assumed in June 2024, following a tenure as Senior Vice President at Kinevant Sciences. With over 25 years of extensive experience in clinical and commercial pharmaceutical settings, Gary Barrera has excelled in various leadership positions, including roles as Global Head of Quality at Allakos Inc. and Vice President at Theravance Biopharma, where responsibilities encompassed quality, drug safety, and operational excellence. Additionally, Gary Barrera has contributed to academia as an Adjunct Professor at Keck Graduate Institute. Academic qualifications include a Bachelor of Arts from the University of California, Berkeley and an MBA from Saint Mary's College of California.
This person is not in any teams
Vera Therapeutics
4 followers
Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases that improve patients’ lives.